• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

带有纳米荧光素酶报告基因的稳定柯萨奇病毒A16感染性克隆的构建与鉴定

The development and characterization of a stable Coxsackievirus A16 infectious clone with Nanoluc reporter gene.

作者信息

Yu Rui, Wang Min, Liu Lizhen, Yan Jingjing, Fan Jun, Li Xiaohong, Kang Miaomiao, Xu Jianqing, Zhang Xiaoyan, Zhang Shuye

机构信息

Shanghai Public Health Clinical Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.

Clinical Center for Biotherapy, Zhongshan Hospital, Fudan University, Shanghai, China.

出版信息

Front Microbiol. 2023 Jan 10;13:1101850. doi: 10.3389/fmicb.2022.1101850. eCollection 2022.

DOI:10.3389/fmicb.2022.1101850
PMID:36704559
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9871592/
Abstract

Coxsackievirus A16 (CA16) belongs to the , which is a common pathogen causing hand, foot, and mouth disease in children. Currently, specific vaccines and drugs against CA16 are unavailable, and there is an unmet need to further understand the virus and invent effective treatment. Constructing a CA16 infectious clone with a reporter gene will greatly facilitate its virological studies. Here, we first reported the construction of a CA16 infectious clone (rCA16) whose progeny is highly replicative and virulent in suckling mice. On the basis of rCA16, we further inserted a NanoLuc (Nluc) reporter gene and made the rCA16-Nluc clone. We found that the Nluc gene in rCA16-Nluc is stable during continuous growing in Vero cells and thus allowed detection of a steady luciferase signal in rCA16-Nluc-infected Vero cells over 10 passages. Its application in antivirals characterization and high-throughput screening is exemplified by measuring IC, CC, and selection index of guanidine hydrochloride, ribavirin, chloroquine, and ammonium chloride against CA16. Finally, we showed that rCA16-Nluc based assay greatly simplified the CA16 neutralizing antibody tests. Thus, these two CA16 infectious clones will be robust tools for future enterovirus studies and antivirals development.

摘要

柯萨奇病毒A16型(CA16)属于 ,是引起儿童手足口病的常见病原体。目前,尚无针对CA16的特异性疫苗和药物,因此迫切需要进一步了解该病毒并研发有效的治疗方法。构建带有报告基因的CA16感染性克隆将极大地促进其病毒学研究。在此,我们首次报道了CA16感染性克隆(rCA16)的构建,其后代在乳鼠中具有高度复制性和致病性。在rCA16的基础上,我们进一步插入了一个纳米荧光素酶(Nluc)报告基因,构建了rCA16-Nluc克隆。我们发现rCA16-Nluc中的Nluc基因在Vero细胞中连续传代过程中稳定,因此在rCA16-Nluc感染的Vero细胞传代10次以上后仍能检测到稳定的荧光素酶信号。通过测定盐酸胍、利巴韦林、氯喹和氯化铵对CA16的半数抑制浓度(IC)、细胞毒性浓度(CC)和选择指数,举例说明了其在抗病毒药物特性鉴定和高通量筛选中的应用。最后,我们表明基于rCA16-Nluc的检测方法大大简化了CA16中和抗体检测。因此,这两个CA16感染性克隆将成为未来肠道病毒研究和抗病毒药物开发的有力工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f1/9871592/35afb001fc44/fmicb-13-1101850-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f1/9871592/a755839eeaf3/fmicb-13-1101850-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f1/9871592/7a187b1ab4d9/fmicb-13-1101850-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f1/9871592/7bfc4e3f59bd/fmicb-13-1101850-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f1/9871592/949f14891286/fmicb-13-1101850-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f1/9871592/6333bb35afe6/fmicb-13-1101850-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f1/9871592/35afb001fc44/fmicb-13-1101850-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f1/9871592/a755839eeaf3/fmicb-13-1101850-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f1/9871592/7a187b1ab4d9/fmicb-13-1101850-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f1/9871592/7bfc4e3f59bd/fmicb-13-1101850-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f1/9871592/949f14891286/fmicb-13-1101850-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f1/9871592/6333bb35afe6/fmicb-13-1101850-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f1/9871592/35afb001fc44/fmicb-13-1101850-g006.jpg

相似文献

1
The development and characterization of a stable Coxsackievirus A16 infectious clone with Nanoluc reporter gene.带有纳米荧光素酶报告基因的稳定柯萨奇病毒A16感染性克隆的构建与鉴定
Front Microbiol. 2023 Jan 10;13:1101850. doi: 10.3389/fmicb.2022.1101850. eCollection 2022.
2
Development and characterization of a clinical strain of Coxsackievirus A16 and an eGFP infectious clone.柯萨奇病毒A16临床毒株及增强绿色荧光蛋白感染性克隆的构建与鉴定
Virol Sin. 2015 Aug;30(4):269-76. doi: 10.1007/s12250-015-3610-7. Epub 2015 Jul 24.
3
A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.一种包含肠道病毒 71 型和柯萨奇病毒 A16 型的联合疫苗能引发针对这两种病毒的均衡保护免疫。
Vaccine. 2014 May 1;32(21):2406-12. doi: 10.1016/j.vaccine.2014.03.012. Epub 2014 Mar 18.
4
Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated Vaccine.柯萨奇病毒A16灭活疫苗候选毒株的优化与特性研究
Viruses. 2015 Jul 17;7(7):3891-909. doi: 10.3390/v7072803.
5
A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.一种新型肠道病毒71型灭活疫苗可在小鼠体内引发针对柯萨奇病毒A16的交叉保护性免疫。
Vaccine. 2016 Nov 21;34(48):5938-5945. doi: 10.1016/j.vaccine.2016.10.018. Epub 2016 Oct 19.
6
Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection.嵌合肠道病毒 71 病毒样颗粒展示保守柯萨奇病毒 A16 表位,引发强烈免疫反应,并保护小鼠免受致死性 EV71 和 CA16 感染。
Vaccine. 2021 Jul 5;39(30):4135-4143. doi: 10.1016/j.vaccine.2021.05.093. Epub 2021 Jun 9.
7
Development of a coxsackievirus A16 neutralization test based on the enzyme-linked immunospot assay.基于酶联免疫斑点分析的柯萨奇病毒A16中和试验的开发。
J Virol Methods. 2015 Apr;215-216:56-60. doi: 10.1016/j.jviromet.2015.02.010. Epub 2015 Feb 19.
8
A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.一种基于病毒样颗粒的二价疫苗可对小鼠肠道病毒71型和柯萨奇病毒A16感染提供双重保护。
Vaccine. 2014 Jul 23;32(34):4296-303. doi: 10.1016/j.vaccine.2014.06.025. Epub 2014 Jun 17.
9
Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection.用柯萨奇病毒 A16 实验性灭活疫苗进行主动免疫接种可诱导中和抗体,并保护小鼠免受致死性感染。
Vaccine. 2013 Apr 26;31(18):2215-21. doi: 10.1016/j.vaccine.2013.03.007. Epub 2013 Mar 13.
10
Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development.昆虫细胞表达的肠道病毒 71 型和柯萨奇病毒 A16 病毒样颗粒的低温电子显微镜研究为疫苗开发提供了结构基础。
J Virol. 2014 Jun;88(11):6444-52. doi: 10.1128/JVI.00200-14. Epub 2014 Mar 26.

引用本文的文献

1
Correlation Analysis of Soil Microbial Communities and Physicochemical Properties with Growth Characteristics of Medicago ruthenica in Different Habitats.不同生境下紫花苜蓿土壤微生物群落、理化性质与生长特性的相关性分析
Curr Microbiol. 2025 Aug 4;82(9):435. doi: 10.1007/s00284-025-04410-y.
2
Development and characterization of a recombinant Senecavirus A expressing enhanced green fluorescent protein.表达增强型绿色荧光蛋白的重组A组赛尼卡病毒的研制与鉴定
Front Microbiol. 2024 Sep 26;15:1443696. doi: 10.3389/fmicb.2024.1443696. eCollection 2024.
3
Enhanced production of recombinant coxsackievirus A16 using a serum-free HEK293A suspension culture system for bivalent enterovirus vaccine development.

本文引用的文献

1
A pseudovirus-based platform to measure neutralizing antibodies in Mexico using SARS-CoV-2 as proof-of-concept.一种基于假病毒的平台,使用 SARS-CoV-2 作为概念验证,在墨西哥测量中和抗体。
Sci Rep. 2022 Oct 26;12(1):17966. doi: 10.1038/s41598-022-22921-7.
2
Hand, Foot and Mouth Disease: A Single Centre Retrospective Study of 403 New Cases and Brief Review of Relevant Indian Literature to Understand Clinical, Epidemiological, and Virological Attributes of a Long-Lasting Indian Epidemic.手足口病:一项对403例新病例的单中心回顾性研究及对相关印度文献的简要综述,以了解一场持久的印度疫情的临床、流行病学和病毒学特征
Indian Dermatol Online J. 2022 May 5;13(3):310-320. doi: 10.4103/idoj.idoj_701_21. eCollection 2022 May-Jun.
3
利用无血清HEK293A悬浮培养系统增强重组柯萨奇病毒A16的生产用于二价肠道病毒疫苗开发。
Vaccine X. 2024 Sep 19;20:100559. doi: 10.1016/j.jvacx.2024.100559. eCollection 2024 Oct.
4
The nucleoside analog 4'-fluorouridine suppresses the replication of multiple enteroviruses by targeting 3D polymerase.核苷类似物4'-氟尿苷通过靶向3D聚合酶抑制多种肠道病毒的复制。
Antimicrob Agents Chemother. 2024 Jun 5;68(6):e0005424. doi: 10.1128/aac.00054-24. Epub 2024 Apr 30.
5
Integration of HiBiT into enteroviruses: A universal tool for advancing enterovirus virology research.将 HiBiT 整合到肠道病毒中:推进肠道病毒病毒学研究的通用工具。
Virol Sin. 2024 Jun;39(3):422-433. doi: 10.1016/j.virs.2024.03.004. Epub 2024 Mar 16.
6
Construction of an infectious clone for enterovirus A89 and mutagenesis analysis of viral infection and cell binding.构建肠道病毒 A89 的感染性克隆及病毒感染和细胞结合的突变分析。
Microbiol Spectr. 2024 Apr 2;12(4):e0333223. doi: 10.1128/spectrum.03332-23. Epub 2024 Mar 5.
7
Reporter Coxsackievirus A5 Expressing iLOV Fluorescent Protein or Luciferase Used for Rapid Neutralizing Assay in Cells and Living Imaging in Mice.柯萨奇病毒 A5 表达 iLOV 荧光蛋白或荧光素酶,用于细胞内快速中和试验和小鼠活体成像。
Viruses. 2023 Sep 2;15(9):1868. doi: 10.3390/v15091868.
8
Construction of coxsackievirus B5 viruses with luciferase reporters and their applications in vitro and in vivo.构建带有荧光素酶报告基因的柯萨奇病毒 B5 病毒及其在体外和体内的应用。
Virol Sin. 2023 Aug;38(4):549-558. doi: 10.1016/j.virs.2023.05.010. Epub 2023 May 26.
A mouse-adapted CVA6 strain exhibits neurotropism and triggers systemic manifestations in a novel murine model.
一种适应小鼠的 CVA6 毒株在新型小鼠模型中表现出嗜神经性,并引发全身性表现。
Emerg Microbes Infect. 2022 Dec;11(1):2248-2263. doi: 10.1080/22221751.2022.2119166.
4
Development of stable, cold-adapted, temperature-sensitive/conditional lethal chimeric enterovirus A71 and coxsackievirus A16.稳定、耐寒、温度敏感/条件致死嵌合肠道病毒 A71 和柯萨奇病毒 A16 的研制。
Virol Sin. 2022 Oct;37(5):769-773. doi: 10.1016/j.virs.2022.08.001. Epub 2022 Aug 11.
5
Development and evaluation of an inactivated coxsackievirus A16 vaccine in gerbils.在沙鼠中开发和评估柯萨奇病毒 A16 灭活疫苗。
Emerg Microbes Infect. 2022 Dec;11(1):1994-2006. doi: 10.1080/22221751.2022.2093132.
6
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors.一种基于细胞的高灵敏度荧光素酶检测法,用于高通量自动化筛选 SARS-CoV-2 nsp5/3CLpro 抑制剂。
Antiviral Res. 2022 May;201:105272. doi: 10.1016/j.antiviral.2022.105272. Epub 2022 Mar 9.
7
Inactivated enterovirus A71 vaccines and moving forward.灭活肠道病毒A71疫苗及未来发展
Lancet Reg Health West Pac. 2021 Oct 20;16:100292. doi: 10.1016/j.lanwpc.2021.100292. eCollection 2021 Nov.
8
Construction and Generation of a Recombinant Senecavirus a Stably Expressing the NanoLuc Luciferase for Quantitative Antiviral Assay.构建并产生一种稳定表达纳米荧光素酶的重组塞内卡病毒A用于定量抗病毒检测。
Front Microbiol. 2021 Oct 1;12:745502. doi: 10.3389/fmicb.2021.745502. eCollection 2021.
9
Preparation and verification of a monoclonal antibody against a conserved linear epitope in enterovirus A protein 2C.抗肠道病毒 A 蛋白 2C 保守线性表位的单克隆抗体的制备与验证。
J Virol Methods. 2021 Dec;298:114298. doi: 10.1016/j.jviromet.2021.114298. Epub 2021 Sep 22.
10
Reverse Genetic Approaches for the Generation of Full Length and Subgenomic Replicon of EV71 Virus.用于生成肠道病毒71型病毒全长和亚基因组复制子的反向遗传学方法。
Front Microbiol. 2021 May 20;12:665879. doi: 10.3389/fmicb.2021.665879. eCollection 2021.